Worldwide Medical Devices sales increased 17.5% on a reported basis and 15.4% on an organic basis in the fourth quarter. Sales growth was led by double-digit organic growth in Diabetes Care, Neuromodulation, Structural Heart, Electrophysiology, Heart Failure, and Rhythm Management.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ABT:
- Options Volatility and Implied Earnings Moves Today, January 24, 2024
- Options Volatility and Implied Earnings Moves This Week, January 22 – January 26, 2024
- Abbott Laboratories (ABT) Q4 Earnings Cheat Sheet
- Abbott announces first procedures using its Volt Pulsed Field Ablation
- Abbott price target raised to $131 from $121 at Wells Fargo
